ID: MRFR/Pharma/1825-HCR | February 2021 | Region: Global | 84 pages
Market Synopsis of Global Alopecia Drugs Market:
Alopecia is loss of hair due to a variety of factors the most important being genetic. The loss of hair due to Alopecia may be partial and restricted to a part of body or complete loss of hair. The market for alopecia drug treatment represents a huge opportunity as America alone spends ~ $ 3 billion on hair loss treatment. The market is also choked with unethical products having no effect on the progress of the condition. In fact many products do more harm than good.
The primary market drivers are genetics, increasing awareness, modern lifestyle changes, stress, drug-induced alopecia etc. The constraining factors are unethical spurious products, poor efficacy and efficiency of treatment resulting in poor economics to the patient, neglect of alopecia as it is not life threatening and noncontagious etc. The market is also extremely fragmented with numerous players small and big and the lifecycle of products is very low. The market is also very susceptible to social currents and advertisements.
The global market for alopecia drugs is expected to reach around $ 11.8 billion by the end of the forecast period and is expected to grow at a CAGR of ~ 6.92%.
Study Objectives Global Alopecia Drugs Market:
Some of the key players in this market are: Cipla Inc., Dr. Reddy’s Laboratories Ltd., Johnson & Johnson, Merck & Co., Ranbaxy Laboratories Ltd, The Himalaya Drug Company, Taisho Pharmaceutical Holdings Co., Sun Pharmaceutical Industries Ltd. and others.
Global Alopecia Drugs market has been segmented on the basis of alopecia type which comprises alopecia areata, alopecia totalis, and alopecia universalis. On the basis of product type; which comprises tropical, oral and others. On the basis of end users; market is segmented into hospitals and clinics, saloons and home care.
Regional Analysis of Global Alopecia Drugs Market:
Globally America is the largest market for alopecia drugs. The American market for alopecia drugs is expected to grow by a CAGR of ~ 4% around $ 3.75 billion by the end of the forecast period of 2016-2022. Europe is the second-largest market for alopecia drugs. Asia pacific region is expected to be fastest growing region in alopecia drugs market.
The report for Global Alopecia Drugs Market of Market Research Future comprises extensive primary research along with the detail analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
|Market Size||USD 11.8 Billion|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Alopecia Type, Product Type and end user|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Cipla Inc., Dr. Reddy’s Laboratories Ltd., Johnson & Johnson, Merck & Co., Ranbaxy Laboratories Ltd, The Himalaya Drug Company, Taisho Pharmaceutical Holdings Co., Sun Pharmaceutical Industries Ltd.|
|Key Market Opportunities||Joint ventures, strategic alliances, mergers and acquisitions, new product developments along with research and developments|
|Key Market Drivers||increasing awareness, modern lifestyle changes, stress, drug-induced alopecia|
Frequently Asked Questions (FAQ) :
Alopecia drugs market valuation can touch USD 11.8 billion by 2022.
Alopecia drugs market can exhibit a CAGR of 6.92% from 2015 to 2022.
Rising stress levels due to current lifestyles of patients and genetics are major drivers of the global alopecia drugs market.
Availability of spurious products and inefficiency of treatment can hamper the global alopecia drugs market growth.
The Americas can dominate the global alopecia drugs market owing to patient spending on hair restoration and scalp problems.
Johnson & Johnson, Cipla Inc., Ranbaxy Laboratories Ltd, The Himalaya Drug Company, Dr. Reddy’s Laboratories Ltd., Merck & Co., Taisho Pharmaceutical Holdings Co., and Sun Pharmaceutical Industries Ltd. are notable players of the global alopecia drugs market.
1.2 Scope of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.5 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porter’s five forces model
4.1.1 Bargaining Power of suppliers
4.1.2 Bargaining Power of Customer
4.1.3 Intensity of Competitor’s
4.1.4 Threat of New Entrants
5 Global Alopecia Drugs market, Alopecia Type
5.2 Alopecia Areata
5.3 Alopecia Totalis
5.4 Alopecia Universalis
6 Global Alopecia Drugs Market, By Product Type
7 Global Alopecia Drugs Market, By Gender
8 Global Alopecia Drugs Market, By End-Users
8.2 Hospitals and Clinics
8.4 Home Care
9 Global Alopecia Drugs market, by Regions
220.127.116.11 North America
18.104.22.168 South America
22.214.171.124 Rest of Europe
9.1.3 Asia Pacific
126.96.36.199 Republic of Korea
188.8.131.52 Rest of Asia Pacific
9.1.4 Middle East & Africa
10 Company Landscape
10.1.1 Mergers Acquisitions
10.1.3 Release/New Product Launches
10.1.4 Other (Expansion, Updates, Partnership)
11 Company Profile
11.1 Cipla Inc.
11.1.1 Company Overview
11.1.2 Product/Business Segment Overview
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.2 Dr. Reddy’s Laboratories Ltd.
11.2.2 Product/Business Segment Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Johnson & Johnson
11.3.2 Product/Business Segment Overview
11.3.4 Key Developments
11.3.5 SWOT Analysis
11.4 Merck & Co.
11.4.2 Product/Business Segment Overview
11.4.4 Key Developments
11.4.5 SWOT Analysis
11.5 Ranbaxy Laboratories Ltd.
11.5.2 Product/Business Segment Overview
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.6 The Himalaya Drug Company
11.6.2 Product/Business Segment Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 Sun Pharmaceutical Industries Ltd
11.7.2 Product/Business Segment Overview
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8.2 Product/Business Segment Overview
11.8.4 Key Developments
11.8.5 SWOT Analysis
List of Tables
TABLE 1 GLOBAL ALOPECIA DRUGS MARKET, 2020-2027 (USD MILLION)
TABLE 2 GLOBAL ALOPECIA DRUGS MARKET, BY ALOPECIA TYPE, 2020-2027 (USD MILLION)
TABLE 3 GLOBAL ALOPECIA DRUGS MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)
TABLE 4 GLOBAL ALOPECIA DRUGS MARKET, BY GENDER, 2020-2027 (USD MILLION)
TABLE 5 GLOBAL ALOPECIA DRUGS MARKET, BY END-USERS, 2020-2027 (USD MILLION)
TABLE 6 GLOBAL ALOPECIA DRUGS MARKET, BY REGION, 2020-2027 (USD MILLION)
List of Figures
FIGURE 1 RESEARCH PROCESS
FIGURE 2 PORTERS FIVE FORCES MODEL
FIGURE 3 GLOBAL ALOPECIA DRUGS MARKET, BY ALOPECIA TYPE
FIGURE 4 GLOBAL ALOPECIA DRUGS MARKET, BY PRODUCT TYPE
FIGURE 5 GLOBAL ALOPECIA DRUGS MARKET, BY GENDER
FIGURE 6 GLOBAL ALOPECIA DRUGS MARKET, BY END-USERS
FIGURE 6 GLOBAL ALOPECIA DRUGS MARKET, BY REGION
FIGURE 7 GLOBAL ALOPECIA DRUGS MARKET: COMPANY SHARE ANALYSIS, 2020 (%)